Prevest Denpro Limited
Prevest Denpro Limited Fundamental Analysis
Prevest Denpro Limited (PREVEST.BO) shows moderate financial fundamentals with a PE ratio of 27.07, profit margin of 27.78%, and ROE of 18.75%. The company generates $0.7B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 79.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze PREVEST.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentPREVEST.BO demonstrates superior asset utilization.
Valuation Score
WeakPREVEST.BO trades at a premium to fair value.
Growth Score
ModeratePREVEST.BO shows steady but slowing expansion.
Financial Health Score
ExcellentPREVEST.BO maintains a strong and stable balance sheet.
Profitability Score
ModeratePREVEST.BO maintains healthy but balanced margins.
Key Financial Metrics
Is PREVEST.BO Expensive or Cheap?
P/E Ratio
PREVEST.BO trades at 27.07 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, PREVEST.BO's PEG of 27.64 indicates potential overvaluation.
Price to Book
The market values Prevest Denpro Limited at 4.64 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 21.73 times EBITDA. This signals the market has high growth expectations.
How Well Does PREVEST.BO Make Money?
Net Profit Margin
For every $100 in sales, Prevest Denpro Limited keeps $27.78 as profit after all expenses.
Operating Margin
Core operations generate 31.36 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.75 in profit for every $100 of shareholder equity.
ROA
Prevest Denpro Limited generates $16.10 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Prevest Denpro Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Prevest Denpro Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
PREVEST.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
27.07
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
27.64
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.64
vs 25 benchmark
P/S Ratio
Price to sales ratio
7.52
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
15.06
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.19
vs 25 benchmark
ROA
Return on assets percentage
0.16
vs 25 benchmark
ROCE
Return on capital employed
0.19
vs 25 benchmark
How PREVEST.BO Stacks Against Its Sector Peers
| Metric | PREVEST.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 27.07 | 29.45 | Neutral |
| ROE | 18.75% | 779.00% | Weak |
| Net Margin | 27.78% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 15.06 | 4.65 | Strong Liquidity |
| ROA | 16.10% | -19344.00% (disorted) | Strong |
PREVEST.BO outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Prevest Denpro Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation